Behavioral Effects of δ-Opioid Receptor Agonists: Potential Antidepressants?
スポンサーリンク
概要
- 論文の詳細を見る
The development of selective δ-opioid receptor agonists has revealed some very intriguing behavioral properties. δ-Opioid agonists have antinociceptive, seizuregenic and convulsive properties. A number of studies have identified a novel behavioral effect of δ-opioid-receptor agonists, implicating a role for the δ-opioid receptor in depression. Early clinical experiments demonstrated that exogenously administered opioid peptides had antidepressant activity in human patients. Also, enkephalinase inhibitors, which prevent the degradation of endogenous enkephalins, produced antidepressant-like effects mediated through the δ-opioid receptor in animal models of depression. More recently, the selective non-peptidic δ-opioid agonists SNC80 and (+)BW373U86 demonstrated antidepressant-like activity in the forced swim assay in rats. These studies propose that the δ-opioid receptor may provide a new therapeutic target for treating human depression.
- 社団法人 日本薬理学会の論文
- 2002-09-01
著者
-
Broom Daniel
Department Of Pharmacology University Of Michigan Medical School
-
Rice Kenner
Niddk (national Institute Of Diabetes & Digestive & Kidney Disease)
-
Jutkiewicz Emily
Department Of Pharmacology University Of Michigan Medical School
-
Woods James
Department Of Pharmacology University Of Michigan Medical School
-
TRAYNOR John
Department of Pharmacology University of Michigan Medical School
-
Jutkiewicz Emily
Department Of Pharmacology University Of Michigan
関連論文
- 5-Hydroxytryptophan Attenuates Somatic Signs of Nicotine Withdrawal
- Behavioral Effects of δ-Opioid Receptor Agonists: Potential Antidepressants?
- 5-Hydroxytryptophan Attenuates Somatic Signs of Nicotine Withdrawal
- Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonines (C-homobenzomorphans).